ABT-751
CAS: 141430-65-1
Ref. 3D-RFA43065
| 5mg | 136.00 € | ||
| 10mg | 172.00 € | ||
| 25mg | 248.00 € | ||
| 50mg | 363.00 € | ||
| 100mg | 518.00 € |
Product Information
- E 7010
- Abt 51
- Abt-751
- Benzenesulfonamide, N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxy-
- E 7010 (pharmaceutical)
- E-7010
- N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide
- N-[2-[(4-Hydroxyphenyl)amino]-3-pyridyl]-4-methoxybenzenesulfonamide
- N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-methoxybenzenesulfonamide
ABT-751 is a novel, potent, and selective inhibitor of autophagy. It has been shown to induce mitochondrial membrane depolarization and autophagy in HL-60 cells. The drug has also been shown to be effective against cancer cells in vitro, with significant cytotoxicity. In a mouse tumor model, the drug inhibited tumor growth without affecting normal tissues. ABT-751 has also been shown to decrease the levels of epidermal growth factor (EGF) in renal cell cancer cells. The drug is currently undergoing clinical trials for the treatment of cancer patients who are on active antiretroviral therapy and for patients with tumors that are resistant to standard chemotherapy treatments.END>
Chemical properties
Technical inquiry about: 3D-RFA43065 ABT-751
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
